Glen Stettin

Glen Stettin

Corporate Officer/Principal presso EXPRESS SCRIPTS HOLDING CO
62 anni
Retail Trade
Consumer Services
Commercial Services

Profilo

Glen D.
Stettin
is Senior VP-Clinical, Research & New Solutions at Express Scripts, Inc. since 2012.
Dr. Stettin is Chief Innovation Officer & Senior VP-Research at Evernorth Health, Inc. since 2012.
Dr. Stettin was Independent Director at PRA Health Sciences, Inc. from 2020 to 2021.
Dr. Stettin was Director at MedAvail, Inc. from 2018 to 2022.
Dr. Stettin was Independent Director at MedAvail Holdings, Inc. from 2020 to 2024.
Dr. Stettin was Chief Medical Officer & Senior Vice President at Medco Health Solutions, Inc. from 2010 to 2012.
Dr. Stettin completed undergraduate studies at Lehigh University.
Dr. Stettin earned a doctorate from Drexel University College of Medicine.

Posizioni attive di Glen Stettin

SocietàPosizioneInizio
EXPRESS SCRIPTS HOLDING CO Corporate Officer/Principal 01/04/2012
Direttore Tecnico/Scientifico/R&S 05/07/2012

Precedenti posizioni note di Glen Stettin

SocietàPosizioneFine
MEDAVAIL HOLDINGS, INC. Direttore/Membro del Consiglio 20/03/2024
Direttore/Membro del Consiglio 01/02/2022
PRA HEALTH SCIENCES, INC. Direttore/Membro del Consiglio 01/07/2021
Direttore Tecnico/Scientifico/R&S 01/04/2012
Vedi nel dettaglio l'esperienza di Glen Stettin

Formazione di Glen Stettin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

57

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Retail Trade

Commercial Services

Health Services

Finance

Consumer Services

Consumer Services

Technology Services

Retail Trade

  1. Mercati
  2. Insiders
  3. Glen Stettin